Objectives: This study aimed to estimate the prevalence of liver fibrosis and assess the risk factors for developing significant liver fibrosis in patients with Thalassemia Major (TM).
Methods: All patients with TM over the age of 10 years were included in the study.
Results: A total of 94 eligible patients underwent 2-D SWE.